To develop a model of human thymus growth in vivo, we have implanted postnatal human thymus under the renal capsule of severe combined immune deficient (SCID) mice and assayed for graft survival and graft characteristics 1-3 mo after engraftment . Three groups of SCID mice were engrafted with postnatal human thymus: untreated SCID mice, SCID mice pretreated with 400 cGy ofy irradiation 1-5 d before engraftment, and SCID mice treated with intraperitoneal anti-asialo GM-1 antiserum every 4-5 d during engraftment . In the untreated group of SCID mice, only 37% ofgrafts survived and consisted ofhuman thymic microenvironment components and human immature thymocytes. Irradiation ofSCID mice before engraftment improved survival of human thymic grafts to 83%, but these grafts were largely devoid of thymocytes and contained only thymic microenvironment components with large numbers of thymic macrophages . Treatment of SCID mice with anti-asialo GM-1 antiserum throughout the engraftment period also promoted human thymus engraftment (70%) and induced SCID B cell Ig production (SCID [Ig+]) in 38% of animals . In SCID(Ig -) anti-asialo GM-1-treated mice, the human thymic grafts were similar in content to those in untreated SCID mice. However, in anti-asialo GM-1-treated animals with grafts that became SCID(Ig+), all animals were found to have mouse-human chimeric grafts in that the human thymic microenvironment (human fibroblasts, thymic epithelium, vessels) was colonized by murine T cells. These data demonstrate that human postnatal thymus will grow as xenografts in SCID mice, and that the components of human thymus that engraft are dependent on the immunosuppressive regimen used in recipient mice. A striking finding in this study was the induction of T and B lymphopoiesis in SCID mice by abrogation of NK cell activity with in vivo anti-asialo GM-1 treatment . These data strongly suggest that asialo GM-1' NK cells and/or macrophages play a role in mediation ofsuppression of lymphopoiesis in SCID mice. cent studies have begun to clarify the early stages of human T cell maturation (1-5). However, a major problem remains in the study of the human T cell lineage in that the intact thymic microenvironment is necessary for T cell precursors to mature through all stages of normal T cell development. The essential requirement of the microenvironment in T cell ontogeny necessitates that the components of thymic stroma be present in models of T lineage development . The use of animal models of T cell development have provided powerful systems to unravel complex cellular interactions that occur in thymic development (6, 7). What is needed in the study of human T cell maturation 167 is a model system that allows for analysis ofthymocyte-thymic microenvironment interactions that occur in vivo.
To develop a model of human thymus growth in vivo, we have implanted postnatal human thymus under the renal capsule of severe combined immune deficient (SCID) mice and assayed for graft survival and graft characteristics 1-3 mo after engraftment . Three groups of SCID mice were engrafted with postnatal human thymus: untreated SCID mice, SCID mice pretreated with 400 cGy ofy irradiation 1-5 d before engraftment, and SCID mice treated with intraperitoneal anti-asialo GM-1 antiserum every 4-5 d during engraftment . In the untreated group of SCID mice, only 37% ofgrafts survived and consisted ofhuman thymic microenvironment components and human immature thymocytes. Irradiation ofSCID mice before engraftment improved survival of human thymic grafts to 83%, but these grafts were largely devoid of thymocytes and contained only thymic microenvironment components with large numbers of thymic macrophages . Treatment of SCID mice with anti-asialo GM-1 antiserum throughout the engraftment period also promoted human thymus engraftment (70%) and induced SCID B cell Ig production (SCID [Ig+] ) in 38% of animals . In SCID(Ig -) anti-asialo GM-1-treated mice, the human thymic grafts were similar in content to those in untreated SCID mice. However, in anti-asialo GM-1-treated animals with grafts that became SCID(Ig+), all animals were found to have mouse-human chimeric grafts in that the human thymic microenvironment (human fibroblasts, thymic epithelium, vessels) was colonized by murine T cells. These data demonstrate that human postnatal thymus will grow as xenografts in SCID mice, and that the components of human thymus that engraft are dependent on the immunosuppressive regimen used in recipient mice. A striking finding in this study was the induction of T and B lymphopoiesis in SCID mice by abrogation of NK cell activity with in vivo anti-asialo GM-1 treatment . These data strongly suggest that asialo GM-1' NK cells and/or macrophages play a role in mediation ofsuppression of lymphopoiesis in SCID mice. cent studies have begun to clarify the early stages of human T cell maturation (1) (2) (3) (4) (5) . However, a major problem remains in the study of the human T cell lineage in that the intact thymic microenvironment is necessary for T cell precursors to mature through all stages of normal T cell development. The essential requirement of the microenvironment in T cell ontogeny necessitates that the components of thymic stroma be present in models of T lineage development . The use of animal models of T cell development have provided powerful systems to unravel complex cellular interactions that occur in thymic development (6, 7) . What is needed in the study of human T cell maturation 167 is a model system that allows for analysis ofthymocyte-thymic microenvironment interactions that occur in vivo.
In 1988, McCune et al. (8) described a system in which human fetal thymic and fetal liver grafts grew in C .B-17 scid/scid (SCID) mice. In the SCID-hu model of McCune et al. (8) , a reduction in the growth potential of thymic xenografts was observed when donor human thymic tissue was >20 wk of gestational age. Unlike human fetal tissue that is not routinely available to most investigators, postnatal human thymic tissue is available as discarded tissue, removed to expose the heart in select pediatric corrective cardiovascular surgical procedures.
In this study, we have studied the growth potential of explants of human postnatal thymus in SCID mice. We demonstrate that human postnatal thymus will grow as xenografts in SCID mice, and that the components of human thymus engrafted vary with the immunosuppressive regimen given to the SCID mouse recipient . Whereas grafts in untreated animals contained both human microenvironment and thymocyte components, grafts in animals irradiated with 400 cGy before engraftment contained predominantly thymic microenvironment components only. When SCID mice were treated with anti-asialo GM-1, an antiserum against murine NK cells and macrophages, 38% of animals were induced to produce murine Ig (i.e., became SCID[Ig+] [9] ). In this group of SCID(Ig') mice, human thymic grafts grew well, were highly lymphoid, but, in contrast to untreated and irradiated SCID recipients, contained human thymic microenvironment components that were populated by murine T cells.
Materials and Methods
Animals . Breeder pairs of SCID (10) mice were obtained from The Jackson Laboratory (Bar Harbor, ME) from the colony of L.
Shultz, and were bred and maintained under pathogen-free conditions in the animal barrier facility at the Duke University Vivarium . Mice were housed in microisolator cages, and all food, caging, and bedding were autoclaved before use. Mice received daily trimethoprim/sulfamethoxazole in suspension in drinking water (40 mg trimethoprim and 200 mg sulfamethoxazole per 320 ml of drinking water). All mice used were between 8 and 19 wk of age.
Placement of Human Thymic Xenografts in SCID Mice. Human postnatal thymic tissue (age, 1 d to 14 mo) was obtained from patients undergoing corrective cardiovascular surgical procedures that require removal of thymic tissue for heart exposure. Thymic tissue was either used immediately for implantation into SCID mice or frozen in RPMI 1640 + 7.5% dimethyl sulfoxide + 15% FCS, and stored in liquid nitrogen for future use.
For engraftment of human thymic tissue into SCID mice, male and female SCID mice were anesthetized with a 1:1 mixture of Ketamine, 5 mg/ml (Aveco, Fort Dodge, IA) and Xylazine, 5 mg/ ml, (Mobay, Shawnee, KA) at the dosage of 0.05 mg/gm. A 2-cm right flank incision was made and the kidney exteriorized . Human postnatal thymic tissue was cut into 1-mm' pieces and placed under the renal capsule using fine forceps. 5-0 sutures were used to approximate the peritoneal layers, and michel clips were placed to close the wound. All surgical procedures were performed under sterile conditions in a laminar flow hood .
After 1-3 mo, mouse thymus, spleen, liver, and kidney with human xenograft were removed, snap frozen in a dry ice/ethanol slurry, and stored in liquid nitrogen . Mouse peripheral blood (PB)' was processed for surface staining of mononuclear cells using anti-human and anti-mouse mAb reagents and analyzed on a FACS Star Plus (Becton Dickinson & Co., Mountain View, CA).
Immunosuppressive Treatment of SCID Mice. Animals engrafted with human postnatal thymic tissue received either no treatment, pretreatment (1-5 d before engraftment) with sublethal whole body ti irradiation (400 cGy) (11), or received long-term intraperitoneal administration (every 4-5 d after graft placement) of 25 1Al of 'Abbreviations used in this paper: DP, double positive; E, eosin; GAM, goat anti-mouse; H, hematoxylin ; Hh-1, hematopoietic histocompatibility 1; hpf, high-powered field; IF, immunofluorescence ; PB, peripheral blood; poly I/polyC, polyinosinic-polycytidyhc acid ; SP, single positive; TE, thymic epithelium . 16 8 Human Thymus Xenografts in SCID Mice anti-asialo GM-1 (Wako, Richmond, VA), a rabbit antiserum against murine NK cells and macrophages (12, 13 (33) . Each antibody was used at an optimal saturating concentration as determined from titration experiments . Control antibodies included either irrelevant mouse mAbs, P3 x 63/Ag8 ascites, or directly labeled murine myeloma paraproteins .
Immunohistologic Staining of Mouse Tissues. Tissue specimens were embedded in OCT compound (Lab Tek Products, Naperville, IL), cut into 4-,um sections, and fixed in acetone (-40°C) for 5 min. Hematoxylin (H) and eosin (E) stains were performed on tissue sections of engrafted kidneys every 120 gm . Tissue sections were used immediately for immunohistologic staining or were stored at -70°C.
Anti-human mouse mAbs were either directly fluoresceinated or used in indirect IF assay with FITC goat anti-mouse IgG (GAM-FITC) (Kirkegaard & Perry Laboratories, Inc., Gathersburg, MD). Anti-mouse mAbs were either directly fluoresceinated or used in indirect IF assays with mouse anti-rat Ig FITC, (0X12-FITC ; Sera Labs). Direct and indirect IF was performed on acetone-fixed, 4-pm tissue sections as previously described (34) . For determination of the relative proportions ofhuman immune cells present in thymic xenografts, the number of CD7, CD3, CD4, CD8, CD1. TCR-0, (OF1), and TCR-S (TCR 61) -positive cells were visually counted using indirect IF and expressed as an estimated percent (to nearest 5%) of human CD45* cells present (35) . For determination of the relative proportions of murine immune cells present in human thymic xenografts and in mouse lymphoid organs, the number of TCR,fl, CD3, CD4, and CD8 -positive cells were visually counted using indirect IF and expressed as an estimated percent (to nearest 10%) of murine Thy-1`cells present (35) .
ELISA for Quantitation of SCID Mouse Ig Levels. A two-site ELISA was used to determine serum levels of murine IgM and IgG. Briefly, goat anti-mouse F(ab') 2 fragments (anti-F[ab']2 fragment specific) were coated onto high-bind EIA microtiter wells (Costar, Cambridge, MA) (2 h, 25°C) . The plates were blocked with 3% BSA (1 h, 25°C) and washed three times with 0.05% Tween 20 in PBS. Twofold dilutions of SCID mouse sera samples were incubated in microtiter wells (1 h, 25°C) . After washing, alkaline phosphatase-conjugated anti-mouse IgM (t~s pecific) (Fisher Scientific Co., Pittsburgh, PA) or anti-mouse IgG (-y specific) (Fisher Scientific Co.) was added (1 :1,000 dilution) (1 h, 25°C). The amount of mouse IgM or IgG bound was measured by hydrolysis of paranitrophenyl phosphate (Sigma Chemical Co.) at 405 nm in an Anthros 2001 ELISA reader (Denley Instruments, Durham, NC). IgM and IgG antibody concentrations for SCID mice were calculated by linear regression analysis from a standard curve generated using purified myeloma proteins of known concentrations : TEPC 183 (IgM, a) (Sigma Chemical Co .) or MOPC 195 (IgG2b, rc) (Litton Bionetics, Kensington, MD). Mice were determined to be "leaky" (SCID[Ig i ]) if murine serum IgM and IgG levels were >50 ttg/ml (9, 36) . Alternatively, in preliminary studies, we also found that reaction of GAM-FITC with SCID mouse tissue was an indicator of SCID(Ig') status, and the reactivity of GAM-FITC with mouse kidney was used to indicate SCID(Ig') status in select animals in whom serum was not available. Table 1 shows the effect of irradiation and anti-asialo GM-1 treatment on the rate of engraftment of human postnatal 169 Barry et al . " Engraftment of human postnatal thymic tissue was defined as visible human thymic tissue present at the time of autopsy that was confirmed as human in origin by immunohistologic staining using anti-human mAbs .
Results

Engraftment of Human Postnatal Thymus in SCID Mice
thymus in SCID mice. Of 84 total mice operated, 47 viable grafts were present after 1-3 mo (56%). 43 untreated SCID animals had human thymic tissue implanted, and after 1-3 mo, 16 (37%) had viable thymus grafts present. In contrast, pretreatment of SCID mice with either sublethal whole body y irradiation (400 cGy) or treatment with anti-asialo GM-1 improved human thymic graft survival to 83 and 70%, respectively.
The average leukocyte counts in engrafted untreated SCID mice were similar to leukocyte counts previously reported in nongrafted SCID mice (37) ( Table 2 ) . Both sublethal irradiation of SCID mice and treatment with anti-asialo GM-1 significantly lowered the lymphocyte count at the time of graft harvest (p < 0.005 and 0.02, respectively). However, only treatment with anti-asialo GM-1 lowered the PB monocyte count (p < 0.001). When PB mononuclear cells were analyzed for a subset of NK cells as defined by mAb SW5E6 (33), we found that both irradiation and anti-asialo GM-1
At the time of autopsy (1-3 mo after implantation of human thymus tissue), mice were bled retroorbitally . Differential counts were performed on Wright-stained PB smears, and total leukocyte counts were determined on a cell counter (Coulter Immunology) . Results are expressed as mean number of PB cells per mm3 t SEM. ' Indirect IF and flow cytometry analysis using NK cell marker SW5E6 was also performed on a subset of mice within each treatment group. PB was taken 4-5 d after injection with anti-asialo GM-1 antisera. For number of SW5E6 4 NK cells, n = 9 for untreated group, n = 8 for irradiation group, and n = 11 for anti-asialo GM-1 group. t Significantly different from untreated group (p < 0 .005) . S Not significantly different from untreated group (p < 0.7). II Significantly different from untreated group (p < 0.01) . 1 Significantly different from untreated group (p < 0.02) . '* Significantly different from untreated group (p < 0.001). treatment significantly decreased the number of SCID PB SW5E6+ NK cells by 83 and 80%, respectively. We next determined ifhuman leukocytes could be detected in mouse PB at the time of autopsy after 1-2 mo of engraftment. Using two-color flow cytometry with directly conjugated CD7-FITC and CD45-PE reagents, rare CD45+, CD7 -cells (69 ± 7 cells/mm 3) were present in PB in engrafted SCID mice in the untreated, engrafted group (n = 3). No circulating human CD45+ cells could be found in engrafted SCID mice treated with either irradiation ( Fig. 1 shows the gross and histologic morphology of representative mouse kidneys (nos . 11-6 and 14-2) bearing 6-and 10-wk human thymic grafts. After 1-2 mo, the human grafts routinely increased in size by threefold. However, when the human thymic grafts from each treatment regimen were tested for the presence of human thymic microenvironment components and for thymocyte subsets, we found the xenografts in each treatment group were dramatically different . 171 Barry et al .
Characterization ofHuman Thymic Grafts in Untreated SCID Mice. After 1-2 mo of engraftment, grafts in the untreated SCID mouse group contained both human thymic microenvironment components and varying numbers of human thymocytes (Table 3) . Immunohistologic analysis of representative graft 2-2 ( Fig. 2) shows thepresence of human thymic microenvironment components, including human fibroblasts and keratin-positive thymic epithelium as defined by anti-human fibroblast marker, TE7 (Fig. 2 B) , anti-human keratin antibody, AE-3 ( Fig . 2 C) , and by the medullary TE cell marker, TE4 (Fig. 2 D) . Of 10 grafts studied using immunohistologic techniques, all had TE7+ thymic fibroblasts present . Moreover, in 9 of 10 grafts, TE7+ cells invaded the renal parenchyma to a depth of 100-400 j.M (Fig . 2 B) . 3 of 10 grafts in untreated mice had only TE7+ fibroblasts present with no AE-3/TE4+ TE cells present, while the remaining seven grafts in this group also contained keratin-positive TE cells .
As seen in Figs. 1 , B and D, and 2 A, human postnatal thymic grafts in SCID mice lost their normal morphology and assumed a dysplastic morphology, with only rare Hassall's bodies present . None of the thymic grafts studied using indirect IF assay had a definable cortico-medullary junction . In grafts that contained TE cells, TE cells formed islands of keratin-positive, TE4+, A2B5+, p19+ thymic epithelium, suggesting that the predominant epithelial cell type was medullary and subcapsular cortical thymic epithelium (24) (25) (26) 30) .
In all but two grafts tested, the TE4+ medullary epithelium was also TE3+ (Fig. 3) . In normal thymus, TE4+ medullary and subcapsular cortical thymic epithelium is mutually exclusive of TE3+ cortical epithelium, except for a minor subset of TE3+, TE4+, normal TE cells in the subcapsular cortical area (26) . TO is also normally expressed intracellularly in thymic fibroblasts and macrophages (26, 38) . Thus, in postnatal thymus grafts in SCID mice, thymic epithelium was not normal and expressed both TE4 and TE3, a phenotype identical to that seen only in a rare subset of normal subcapsular cortical TE cells (26) .
Human vessels were present throughout thymic grafts in the untreated SCID mouse group, and varied in size from small capillaries to large muscular arteries. As with TE7+ cells, V2+ endothelial cells routinely invaded the underlying renal parenchyma . In two to five grafts tested, human vessels were positive for human fibronectin, LFA-3, ICAM-1, and VLA /3 (data not shown) (reviewed in references 1, 39, and 40) .
In untreated SCID mice with human thymic grafts, the human lymphoid component of the thymic graft varied in number and in phenotype. Table 3 shows an analysis of six human grafts present in untreated SCID mice. Human lymphoid cells present in untreated SCID mice were either CD4+, CD8+, CD1+ cells (graft 2-2) (Fig. 4) , CD4+, 3 and 6-9 ) . When reacted with either OR (antiTCR /3) and TCR-S1 (antiTCR-S), most thymocytes were TCR a+ (grafts 3-1 and 3-8) with only rare (one to two cells positive per slide) TCR-S+ cells present . In grafts 6-3 and 6-9, most of the CD45+ cells present were both TCR-0 -and TCR-S - (Table 3 ) . In three grafts (9-4, 9-5, and 9-13), only TE7+ fibroblasts were present without either CD45+ human lymphoid cells or keratin-positive TE cells (data not shown) . Fig . 4 shows the lymphoid component of a 4-wk human postnatal thymic graft (no . 2-2) in an untreated, engrafted SCID mouse. Fig. 4 , B-F, shows human thymocytes in the graft stained with human T cell lineage markers CD7, CD4, CD8, CD3, and CD1 ; most thymocytes present in graft 2-2 reacted with all of these antibodies . Interestingly, in untreated SCID mice, using antibody Leu-M3 as a human macrophage marker, we found only rare Leu-M3+ cells (Table 3) . Using mAbs specific for mouse T cells (CD3E, Thy-1), we found that 50% of grafts in this group contained rare (1-3 cells/section) murine T cells . Finally, of the untreated mice with viable human thymic grafts, none were found to be SCID (Ig+) at the time of graft harvest .
Characterization ofHuman Postnatal Thymus Grafts in SCID Mice Pretreated with 400 cGy y Irradiation . In contrast to untreated SCID mice, when animals were treated with 400 cGy y irradiation before engraftment, the resulting grafts were comprised primarily of thymic microenvironment components only, and were markedly depleted of human or murine T cells in seven of nine grafts tested . Table 4 summarizes the characterization of nine thymus grafts studied from animals that had been irradiated before engraftment . In contrast to human thymus grafts in untreated SCID mice, Leu-M3+ macrophages were observed in irradiated SCID mice in seven of nine thymus grafts and were present in large numbers (>20 cells/high-powered field [hpl) in five grafts . Fig. 5 shows a representative human thymus graft (no. 13-1) in the irradiation treatment group. Graft 13-1 contained human fibroblasts (Fig. 5 A) , keratin-positive human thymic epithelium (Fig . 5 B) , numerous human thymic macrophages (Fig . 5 C) , and V2+ endothelial cells (Fig . 5 D) . Human V2+ endothelial cells routinely invaded the murine renal parenchyma (Fig, 5 D) , as did TE7+ human fibroblasts (data not shown) . Only two of nine animals studied in this group had clusters of CD45+, CD3+ human T cells present in thymus grafts . Most of the T cells present in graft 8-11 were CD4-, CD8-, TCR-(3+ cells, while CD1+, CD4', CD8+, TCR(3+ cells predominated in graft 8-14 (Table 4) . Otherwise, only thymic microenvironment components predominated in human thymic grafts in irradiated animals. As with the untreated Table 4 . Characterization of Human Postnatal Thymic Grafts Placed in SCID Mice Pretreated with 400 cGy y Irradiation 17 4 Human Thymus Xenografts in SCID Mice SCID group, either no or rare murine T cells were present in human thymic grafts placed in irradiated SCID recipients . In addition, no irradiated mice with viable human xenografts were found to be SCID(Ig+) at the time of graft harvest. Characterization ofHuman Postnatal Thymus Grafts in SCID Mice Treated With Anti-asialo GM-1 . To further facilitate engraftment of human thymic tissue, we treated SCID animals with anti-asialo GM-1 antiserum to decrease NK cell and monocyte/macrophage number and function (12, 13) . Of 23 grafts implanted in this group, 16 (70%) human thymic grafts survived and grew. Surprisingly, at 1-2 mo after engraftment, of 16 animals with viable thymus grafts, six (38%) had become SCID(Ig+).
In anti-asialo GM-1-treated animals that were SCID(Ig -) at autopsy, thymus grafts were similar to grafts in untreated Table 6 . Characterization of Human Postnatal Thymic Grafts in Anti-asialo GM-1-treated SCID (Ig*) Mice animals, with thymic microenvironment components with varying numbers of thymocytes, and only rare Leu-M3+ macrophages present (Table 5 ) .
In five of six anti-asialo GM-1-treated mice that were SCID(Ig+) at the time of graft harvest, large lymphoid grafts were present under the renal capsule (Fig . 1, C and  D) . However, in striking contrast to anti-asialo GM-1-treated SCID(Ig -) mice, none of the lymphoid cells in human thymic grafts in SCID(Ig+) anti-asialo GM-1-treated mice 175 Barry et al . were human T cells. Rather, 100% of the lymphoid cells colonizing human thymic microenvironment components were murine CD3e+, TCR-(3+ SCID T cells (Table 6 , Fig.  6 ) . In direct IF assays, the chimeric thymus grafts contained murine T cells that varied in phenotype from all CD4+ single-positive (SP) cells (no. 10-6) to mixtures of CD4+ and CD8+ cells (nos. 10-7, 14-2, and 14-9) ( Table 6 ) . In double staining experiments on grafts from animals 14-2 and 14-9, the expression of murine CD4 and CD8 was found +  +  ND  +  ND  0  100  100  100 Rare  100  10-7  82  +  +  ND  +  +  Rare  100  100  60  40  100  11-9  71  ---+  ND  0  Rare  Rare  0  0  Rare  11-10  71  +  ND ND  +  -0  100  10  20  0  100  14-2  89  +  +  ND  +  -0  100  100  80  20  100  14-9  89  +  +  ND  +  +  0  100  100  80  20 to be mutually exclusive in the majority of mouse lymphocytes (ti90%), although these techniques could not rule out the presence of a small proportion of CD4+, CD8+ doublepositive (DP) cells. Murine TCR-/3+ T cells were present in and around human thymic epithelium, and as well were scattered throughout TE7+ human thymic fibroblasts . TE7+ cells invaded the renal parenchyma, 100-400 /.M, and murine T cells were scattered in interstitial areas of the mouse kidney in a similar zone around the human graft. In the kidney interstitium, mouse T cells were frequently in close proximity to human TE7+ cells (data not shown) . Determination of the Effects of Anti-asialo GM-1 Treatment on Induction of SCID(Ig+) Status in SCID Mice. In our initial set of experiments, we found that 38% of anti-asialo GM-1-treated mice with thymus xenografts became SCID(Ig+) 2-3 mo after engraftment, as compared with 0% of mice in the untreated and irradiated groups . To clarify the factors responsible for induction of SCID(Ig+) status, age-matched SCID(Ig+) mice were treated with either anti-asialo GM-1 alone, anti-asialo GM-1 plus engraftment, or normal rabbit serum (50 1.1, i.p.), and the presence of serum mouse Ig was determined after 60 d. Of nine SCID(Ig-) mice treated with normal rabbit serum every 4 d, none became SCID(Ig+) after 2 mo . However, in 10 SCID(Ig-) mice treated with anti-asialo GM-1 every 4 d but not engrafted, four (40%) became SCID(Ig+) after 2 mo . Moreover, of an additional 17 6 Human Thymus Xenografts in SCID Mice 35 anti-asialo GM-1-treated, engrafted animals, 14 (40%) became SCID(Ig+) after 2 mo . Taken together, these data demonstrate that long-term intraperitoneal administration of anti-asialo GM-1 antiserum alone led to induction of SCID (Ig+) status in -40% of SCID mice, suggesting a role for NK cell-and/or monocyte-mediated suppression of lymphopoiesis in these animals. Phenotype of Murine T Lineage Cells in SCID Mouse Lymphoid Tissues in Various Groups of SCID Mice. We next evaluated mouse lymphoid cells present in mouse spleen and thymus of SCID mice in all three treatment groups (Table 7) . First, as normal controls, three age-matched (161 d), untreated, nonengrafted SCID mice were screened for mature mouse T cells in spleen and thymus . As reported previously, SCID (Ig -) mouse thymus contained Thy-1+, cCD3+, TCR-0-cells with rare CD4+, CD8+ cells present (42) . In one age- In nongrafted control SCID mice, no human thymic grafts were implanted. t was SCID(Ig') at time of study. had large clusters of murine TCR-,3+ cells in mediastinal thymus and in spleen in two of three animals tested (nos. 14-2 and 14-9). Moreover, large numbers (10-50 cells/hpf) of CD4+ and/or CD8+ cells in thymus and spleen were present in all three anti-asialo GM-1-treated animals that became SCID(Ig+) . One such animal (no . 11-10) had large numbers of CD4+ and/or CD8+ cells in thymus and spleen, but no TCR-O+ cells present. Interestingly, this animal also had subsets of murine cCD3+, CD4 -, CD8 -, TCR-0-and cCD3+, CD4+, CD8 -, TCR-0 -cells in the human thymus graft, documenting in this animal the homing ofimmature SCID mouse T cells to the human thymic xenograft (Table 6 ).
Discussion
In this study, we have shown that human postnatal thymic tissue will grow as xenografts in SCID mice. The components of the human thymic grafts at 1-3 mo varied with the immunosuppressive regimen used in the SCID mouse recipient. Xenografts from untreated SCID mice contained both human thymic microenvironment and thymocytes, whereas irradiation ofSCID mice before engraftment yielded primarily human thymic microenvironment grafts containing human macrophages but devoid of human or murine thymocytes. Treatment of SCID mice with anti-asialo GM-1 after engraftment resulted in murine B cell antibody production (SCID[Ig+]) in 38% of animals. Remarkably, in five of the six SCID(Ig+) mice, the human thymic grafts grew well, were highly lymphoid, but in contrast to untreated and irradiated SCID recipients, contained exclusively murine TCR-a+ T cells.
Mice homozygous for the SCID mutation exhibit markedly impaired lymphopoiesis, while myelopoiesis is unaffected (10, 43) . Despite this selective deficiency, SCID mice have normal levels of NK cells and NK cell precursors and show levels of NK cell activity similar to their C.B-17 counterparts (44) (45) (46) . While in vivo treatment with anti-asialo GM-1 antiserum has been used in several mouse strains to abrogate NK activity, its use in SCID mice to enhance engraftment of human tissue has not been reported .
The observation that anti-asialo GM-1 treatment alone induced -40% of SCID mice to become SCID(Ig+) was a striking finding in our study and may provide insights into cellular controls ofthe recombinase defect in SCID mice (47, 48) . Induction of both T and B cell lymphopoiesis by anti-asialo GM-1 antiserum raises the notion that there may be a cell-mediated suppression ofB and T cell lymphopoiesis involving NK cells, macrophages, or both cell types in SCID mice. For example, SCID NK cells and/or monocytes could act by eliminating or suppressing the function ofcells responsible for the production of cytokines necessary for induction of recombinase in SCID T and B cell precursors (reviewed in reference 49). Alternatively, SCID NK cells could suppress SCID lymphopoiesis by selective NK-mediated killing ofautologous SCID lymphoid precursors. Murphy et al. (50) have recently demonstrated in the setting of bone marrow transplantation in SCID mice that NK cells can inhibit lym-phopoiesis, in that NK cells can mediate the rejection of T cell-depleted bone marrow allografts. Murphy et al. (51) have gone on to show that adoptively transferred SCID NK cells can mediate hematopoietic histocompatibility 1 (Hh-1)-mediated bone marrow rejection in vivo. Taken together with the data in our current study, these observations raise the hypothesis that SCID NK cells may mediate killing of autologous SCID lymphocyte precursors via the Hh-1 antigen system.
In those anti-asialo GM-1-treated SCID(Ig+) animals in which human thymus grafts were present, the grafts were chimeric in that they contained human thymic microenvironment components colonized exclusively by murine TCR/3+ T cells. The homing of murine TCR #+ T cells to the human thymic microenvironment in SCID mice treated with antiasialo GM-1 could represent an attempt at thymus graft rejection, or alternatively, could represent maturation ofSCID mouse T cell precursors in the human thymic microenvironment. In mouse 11-10, the murine T cells were TCR-/3-and were immature, demonstrating homing of immature mouse T cells to the human xenograft at least in this one animal. If the presence of murine T cells in human thymic microenvironment grafts proves to represent colonization of human thymic stroma with developing mouse thymocytes, then this model system should be important for the determination of optimal methods for reconstitution of the human T cell lineage across HLA barriers . Murine CTL precursors have been reported to be positively selected during development to recognize human HLA-A2 as a restricting element in HLAA2 transgenic mice (52) . In nude mice engrafted with xenogenic rat thymus, chimeric grafts develop with mouse T cell precursors colonizing the rat thymic microenvironment (53) . Moreover, we have recently shown human TE cells can bind to SCID mouse thymocytes in vitro (Singer, K.H., and B.F. Haynes, unpublished results). Thus, it is plausible that developing mouse T cells could colonize a human thymic microenvironment . Human thymocytes were rare in grafts in anti-asialo GM-1-treated SCID(Ig+) mice and in irradiated SCID mice. In irradiated animals, the potential is present for vascular injury to occur due to irradiation, predisposing thymocytes to die out due to delayed vascularization . Moreover, although we showed human thymocytes and thymic macrophages were anti-asialo GM-1 negative in indirect IF assays, anti-asialo GM-1 could react with human thymocytes or with macrophages at levels too low to detect in vitro in IF assays, yet react at levels sufficient to result in thymocyte loss in vivo.
It is not clear why human/mouse chimeric grafts were seen in anti-asialo GM-1-treated mice and not seen in irradiated SCID mice. Total body sublethal y irradiation has been shown to markedly reduce murine NK activity (54) . 400 cGy of y irradiation has been reported to be required for engraftment of SCID mice with syngeneic bone marrow (9) ; this level ofy irradiation has also been shown to damage SCID B lymphocyte precursors (11) . Thus, it is likely that 400 cGy irradiation damaged murine lymphoid precursors and prevented murine T and B cell lymphopoiesis both in SCID hematopoietic microenvironments and in the engrafted human thymic microenvironment .
The presence of numerous Leu-M3+ tissue macrophages in thymic microenvironment grafts in irradiated SCID recipients is intriguing and suggests that macrophage precursors are present in human thymus that are capable of continuously growing in irradiated but not in untreated or anti-asialo GM-1-treated SCID mice (55, 56 In the present study, in all three groups of SCID mice, there was a hierarchy of cell survival in human thymic grafts placed, with fibroblasts and endothelial cells surviving longer than TE cells, and TE cells surviving longer than thymocytes. The paucity of thymocytes in several of the human thymic grafts in untreated SCID mice could indicate a limited regenerating capacity ofpostnatal T cell precursor cells within human thymus . In mice, reconstitution of bone marrow chimeras with murine postnatal CD4 -,CD8-,CD3 -thymocytes only transiently reconstituted mouse mature thymocyte populations (58, 59 ). While we observed human thymic grafts containing TE cells with no thymocytes, we did not see human thymic grafts with thymocytes in the absence of human TE cells. These data suggest dependence of thymocytes on TE cells, and dependence of TE cells on fibroblasts and endothelial cells to grow in vivo (reviewed in references 1 and 38) . Indeed, a role for fibroblast-produced cytokines on human TE cell growth has been suggested to be important in early thymic organogenesis (reviewed in reference 38) .
Finally, it is important to compare the system described in the present report with the SCID-hu system of McCune et al. (8) . The simultaneous transplantation of human fetal thymus and fetal liver by McCune et al. gave rise to thymic grafts containing the thymic microenvironment from the human donor thymus and thymocytes and dendritic cells from the fetal liver (8) . Experiments were not reported on the fate of human fetal thymus grafts placed in SCID mice alone, although thymus grafts from donors >20 wk of gestational age were reported to grow less well than grafts from earlier tissues (8) . Our study demonstrates that human postnatal thymus tissue from children of 1-14 mo gestational age grow in SCID mice and routinely increased in size by threefold over a 60-d period . The size increase observed in our study was less than that reported by McCune et al., perhaps for two reasons: (a) none of our engrafted animals were simultaneously given a source of bone marrow or fetal liver stem cells; and (b) all tissue was postnatal, possibly with reduced growth potential as compared with fetal thymus tissue. Against the latter possibility is the observation that in children who undergo multiple thoracotomies for corrective cardiovascular surgery in whom >95% of thymic tissue was removed at the initial operation, the thymus is frequently observed to have regenerated by the time of subsequent operations (R. Ungerleider, Duke University, personal communication) . Presently, experiments are underway to attempt to reconstitute human thymic microenvironment grafts in irradiated SCID mice with human bone marrow CD7+ T cell precursors (1, 2) to resolve this issue. Namikawa et al. (60) have recently reported long-term survival of multilineage hematopoietic precursors in fetal thymus grafts implanted with fetal liver grafts. In contrast to the thymic grafts described by Namikawa et al. (60) and McCune et al. (8) , our thymic grafts have a dysplastic morphology (Fig. 3) . If reconstitution experiments using T cell precursors in our system does not promote normal postnatal thymic growth and histogenesis, then this could be a major limitation of the SCID-Hu model using postnatal thymus.
Thus, the use of human postnatal thymic tissue grafts in immunosuppressed SCID mice provides an easily accessible model for the study of human thymocyte development and human thymic microenvironment function. Moreover, study ofthe mechanisms ofaction ofanti-asialo GM-1 in inducing T and B cell lymphopoiesis should provide insights into the cellular control of lymphopoiesis . Finally, study of human/ mouse chimeric thymus grafts in SCID(Ig') anti-asialo GM-1-treated mice provides a unique model to study evolutionarily conserved mechanisms ofTE-thymocyte interactions.
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